Cardiff Metropolitan University
PIIS2666524722001902.pdf (51.96 kB)
Download file

Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?

Download (51.96 kB)
journal contribution
posted on 2022-09-12, 15:08 authored by Patrick M. Meyer Sauteur, Victoria J. Chalker, Christoph Berger, Ran Nir-Paz, Mike BeetonMike Beeton, ESGMAC–MyCOVID Study Team

 Mycoplasma pneumoniae is a major bacterial cause of respiratory tract infection.1 We recently established a collaborative global network to assess the impact of non-pharmaceutical interventions (NPIs) against COVID-19 on transmission of M. pneumoniae. Data collected through this network showed significantly reduced M. pneumoniae incidence in the first year after implementation of NPIs (1 April 2020–31 March 2021) compared with previous years (2017–2020) (1.69% vs 8.61%),2 as observed for other respiratory infections.3 Lifting of NPIs has led to resurgence of many respiratory pathogens.4,5 Here, we used this network to track M. pneumoniae in the second year after implementation of NPIs (1 April 2021–31 March 2022), during which NPIs were relaxed or discontinued.  


Published in

The Lancet Microbe




  • VoR (Version of Record)


Sauteur, P.M.M., Chalker, V.J., Berger, C., Nir-Paz, R., Beeton, M.L., Pereyre, S., Bébéar, C., Wagner, N., Andreutti, C., Greub, G. and Agyeman, P.K.,(2020) 'Mycoplasma pneumoniae beyond the COVID-19 pandemic: where is it?',. The Lancet Microbe. DOI: 10.1016/S2666-5247(22)00190-2

Electronic ISSN


Cardiff Met Affiliation

  • Cardiff School of Sport and Health Sciences

Cardiff Met Authors

Mike Beeton

Cardiff Met Research Centre/Group

  • Microbiology & Infection

Copyright Holder

  • © The Publisher


  • en